Gamco Investors INC. ET AL Has $9.57 Million Holdings in Chemed Corporation $CHE

Gamco Investors INC. ET AL grew its holdings in shares of Chemed Corporation (NYSE:CHE) by 9.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,376 shares of the company’s stock after purchasing an additional 1,928 shares during the period. Gamco Investors INC. ET AL’s holdings in Chemed were worth $9,574,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Alps Advisors Inc. grew its position in shares of Chemed by 32.4% during the 3rd quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock worth $19,833,000 after purchasing an additional 10,845 shares in the last quarter. Van Berkom & Associates Inc. grew its position in shares of Chemed by 33.0% during the 3rd quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock worth $76,480,000 after purchasing an additional 42,390 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Chemed by 773.5% during the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after acquiring an additional 23,436 shares in the last quarter. Vest Financial LLC boosted its position in shares of Chemed by 32.6% during the 3rd quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock worth $4,344,000 after acquiring an additional 2,383 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in shares of Chemed by 6.5% during the 3rd quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock worth $35,855,000 after acquiring an additional 4,865 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 3.33% of the stock is owned by corporate insiders.

Chemed Stock Performance

Shares of Chemed stock opened at $440.67 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The firm has a market capitalization of $5.85 billion, a P/E ratio of 24.01, a P/E/G ratio of 1.66 and a beta of 0.54. The company’s 50 day moving average price is $397.97 and its two-hundred day moving average price is $424.97.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. Chemed’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts forecast that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is currently 13.08%.

Analysts Set New Price Targets

Several research firms recently issued reports on CHE. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada increased their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Oppenheimer reduced their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed currently has an average rating of “Hold” and an average target price of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.